Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Neugebauer

Showing results (131-140 of 382) with videos related to

Pageof 39
Sort By:
Plos One|June 11, 2014
Ground reaction force estimates from ActiGraph GT3X+ hip accelerationsJennifer M Neugebauer, Kelsey H Collins, David A Hawkins
BMC Public Health|August 24, 2010
Adaptive coping strategies in patients with chronic pain conditions and their interpretation of diseaseArndt Büssing, Thomas Ostermann, Edmund A M Neugebauer, et al.
Behavioural Brain Research|November 1, 2015
Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognitionMasanori Miyauchi, Nichole M Neugebauer, Yoshihiro Oyamada, et al.
Zeitschrift Fur Rechtsmedizin. Journal of Legal Medicine|January 1, 1986
[Cleavage of 2-phenylpropan-1-ol and 2-phenylpropan-2-ol-glucuronide, 2 metabolites of isopropylbenzol (Cumol)]S Goenechea, G Rücker, G Hoffmann, et al.
American Journal of Medical Genetics|February 1, 1991
Gene for non-specific X-linked mental retardation maps in the pericentromeric regionC Samanns, R Albrecht, M Neugebauer, et al.
International Journal of Technology Assessment in Health Care|January 1, 2019
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS - ERRATUMMiriam Luhnen, Barbara Prediger, Edmund A M Neugebauer, et al.
Neuropsychiatric Disease and Treatment|April 11, 2025
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or HarmedLeslie Citrome, Nichole M Neugebauer, Alicia A Meli, et al.
International Journal of Technology Assessment in Health Care|October 23, 2018
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODSMiriam Luhnen, Barbara Prediger, Edmund A M Neugebauer, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinibPaulina Podszywałow-Bartnicka, Morgan Shine, Jing Lin, et al.
Science Advances|March 20, 2026
Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinibPaulina Podszywałow-Bartnicka, Morgan Shine, Jing Lin, et al.
Pageof 39

Showing results (131-140 of 382) with videos related to

Sort By:
Pageof 39
Plos One|June 11, 2014
Ground reaction force estimates from ActiGraph GT3X+ hip accelerationsJennifer M Neugebauer, Kelsey H Collins, David A Hawkins
BMC Public Health|August 24, 2010
Adaptive coping strategies in patients with chronic pain conditions and their interpretation of diseaseArndt Büssing, Thomas Ostermann, Edmund A M Neugebauer, et al.
Behavioural Brain Research|November 1, 2015
Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognitionMasanori Miyauchi, Nichole M Neugebauer, Yoshihiro Oyamada, et al.
Zeitschrift Fur Rechtsmedizin. Journal of Legal Medicine|January 1, 1986
[Cleavage of 2-phenylpropan-1-ol and 2-phenylpropan-2-ol-glucuronide, 2 metabolites of isopropylbenzol (Cumol)]S Goenechea, G Rücker, G Hoffmann, et al.
American Journal of Medical Genetics|February 1, 1991
Gene for non-specific X-linked mental retardation maps in the pericentromeric regionC Samanns, R Albrecht, M Neugebauer, et al.
International Journal of Technology Assessment in Health Care|January 1, 2019
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS - ERRATUMMiriam Luhnen, Barbara Prediger, Edmund A M Neugebauer, et al.
Neuropsychiatric Disease and Treatment|April 11, 2025
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or HarmedLeslie Citrome, Nichole M Neugebauer, Alicia A Meli, et al.
International Journal of Technology Assessment in Health Care|October 23, 2018
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODSMiriam Luhnen, Barbara Prediger, Edmund A M Neugebauer, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinibPaulina Podszywałow-Bartnicka, Morgan Shine, Jing Lin, et al.
Science Advances|March 20, 2026
Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinibPaulina Podszywałow-Bartnicka, Morgan Shine, Jing Lin, et al.
Pageof 39